Insider · CIK 0001777962
Pardeep Nijhawan
Files at EDSA (Edesa Biotech, Inc.). First filing Mar 2, 2026, latest Mar 10, 2026.
In brief
Pardeep Nijhawan files SEC Form 4 as CEO, director and 10% owner at EDSA (Edesa Biotech, Inc.). Since Mar 2, 2026, Pardeep Nijhawan has reported 6 open-market buys worth $230k and 0 open-market sells worth $0, the latest filed on Mar 10, 2026.
A track record needs three past buys with six months of prices behind them; Pardeep Nijhawan has 0, so none is measured yet.
The newest scored trade: bought $6,599 of EDSA on Mar 10, 2026, filed Mar 10, 2026, scored 33 (weak). In the last 12 months: 6 buys worth $230k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EDSA: Edesa Biotech, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | Edesa Biotech, Inc. | $6,599 1,000 shares | +0% | - | |
| 44Moderate | Edesa Biotech, Inc. | $39k 10,000 shares | +3% | - | |
| 44Moderate | Edesa Biotech, Inc. | $43k 10,000 shares | +3% | - | |
| 44Moderate | Edesa Biotech, Inc. | $36k 10,000 shares | +3% | - | |
| 33Weak | Edesa Biotech, Inc. | $6,280 3,000 shares | +0% | - | |
| 46Moderate | Edesa Biotech, Inc. | $99k 50,571 shares | +8% | - |
Transactions
Every row this insider has filed, 39 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +6,893 | $0.00 | $0 | 905,993 | 7 d ago |
| Sep 1, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +5,714 | $0.00 | $0 | 899,100 | 42 d ago |
| Aug 3, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +5,324 | $0.00 | $0 | 893,386 | Aug 4, 2026 |
| Jul 2, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +3,378 | $0.00 | $0 | 888,062 | Jul 2, 2026 |
| Jun 16, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +153,550 | $5.21 | $800k | 884,684 | Jun 16, 2026 |
| Jun 1, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +1,671 | $0.00 | $0 | 731,134 | Jun 1, 2026 |
| May 27, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +96,913 | $0.00 | $0 | 729,463 | May 29, 2026 |
| May 1, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +1,159 | $0.00 | $0 | 632,550 | May 1, 2026 |
| Apr 1, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +2,578 | $0.00 | $0 | 631,391 | Apr 10, 2026 |
| Mar 10, 2026 | EDSA Edesa Biotech, Inc. | POpen-market purchase Common Shares | +1,000 | $6.60 | $6,599 | 628,813 | Mar 10, 2026 |
| Mar 5, 2026 | EDSA Edesa Biotech, Inc. | POpen-market purchase Common Sharesindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +10,000 | $3.90 | $39k | 402,702 | Mar 6, 2026 |
| Mar 4, 2026 | EDSA Edesa Biotech, Inc. | POpen-market purchase Common Sharesindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +10,000 | $4.26 | $43k | 392,702 | Mar 5, 2026 |
| Mar 3, 2026 | EDSA Edesa Biotech, Inc. | POpen-market purchase Common Sharesindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +10,000 | $3.63 | $36k | 382,702 | Mar 4, 2026 |
| Mar 2, 2026 | EDSA Edesa Biotech, Inc. | POpen-market purchase Common Shares | +2,000 | $2.00 | $4,000 | 627,813 | Mar 3, 2026 |
| Mar 2, 2026 | EDSA Edesa Biotech, Inc. | POpen-market purchase Common Sharesindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +1,000 | $2.28 | $2,280 | 372,702 | Mar 3, 2026 |
| Feb 26, 2026 | EDSA Edesa Biotech, Inc. | POpen-market purchase Common Shares | +20,571 | $1.58 | $32k | 615,797 | Mar 2, 2026 |
| Feb 19, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +82,236 | $0.00 | $0 | 595,226 | Mar 2, 2026 |
| Mar 2, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +10,016 | $0.00 | $0 | 625,813 | Mar 2, 2026 |
| Feb 27, 2026 | EDSA Edesa Biotech, Inc. | POpen-market purchase Common Sharesindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +30,000 | $2.22 | $67k | 371,702 | Mar 2, 2026 |
| Feb 2, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +11,168 | $0.00 | $0 | 512,990 | Feb 2, 2026 |
| Jan 5, 2026 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +10,444 | $0.00 | $0 | 501,822 | Jan 5, 2026 |
| Dec 1, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +8,766 | $0.00 | $0 | 491,378 | Dec 2, 2025 |
| Nov 3, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +6,968 | $0.00 | $0 | 482,612 | Nov 6, 2025 |
| Oct 2, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +5,908 | $0.00 | $0 | 475,644 | Oct 3, 2025 |
| Sep 11, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +5,981 | $0.00 | $0 | 469,736 | Sep 12, 2025 |
| Aug 1, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +6,802 | $0.00 | $0 | 463,755 | Aug 4, 2025 |
| Jul 2, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +7,186 | $0.00 | $0 | 456,953 | Jul 2, 2025 |
| May 29, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +263,200 | $0.00 | $0 | 442,123 | Jun 2, 2025 |
| Jun 2, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +7,644 | $0.00 | $0 | 449,767 | Jun 2, 2025 |
| May 2, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +6,392 | $0.00 | $0 | 178,923 | May 6, 2025 |
| Apr 1, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +5,784 | $0.00 | $0 | 172,531 | Apr 3, 2025 |
| Mar 3, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +6,339 | $0.00 | $0 | 166,747 | Mar 3, 2025 |
| Feb 12, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Series B-1 Convertible Preferred Sharesderivative | +100 | - | - | 100 | Feb 14, 2025 |
| Feb 3, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +8,264 | $0.00 | $0 | 160,408 | Feb 4, 2025 |
| Jan 6, 2025 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +8,476 | $0.00 | $0 | 152,144 | Jan 6, 2025 |
| Dec 2, 2024 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +6,420 | $0.00 | $0 | 143,668 | Dec 3, 2024 |
| Nov 12, 2024 | EDSA Edesa Biotech, Inc. | AGrant or award Common Shares | +4,630 | $0.00 | $0 | 137,248 | Nov 12, 2024 |
| Oct 30, 2024 | EDSA Edesa Biotech, Inc. | AGrant or award Series A-1 Convertible Preferred Sharesderivativeindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +150 | - | - | 150 | Nov 1, 2024 |
| Oct 30, 2024 | EDSA Edesa Biotech, Inc. | AGrant or award Warrants (right to buy)derivativeindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +326,560 | - | - | 326,560 | Nov 1, 2024 |
Questions about Pardeep Nijhawan
Answered from the filings on this page, as of the latest one.
Is Pardeep Nijhawan buying or selling?
In the last 12 months Pardeep Nijhawan reported 6 open-market buys worth $230k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $6,599 of EDSA on Mar 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Pardeep Nijhawan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Pardeep Nijhawan has 0.
Where does Pardeep Nijhawan file Form 4?
Pardeep Nijhawan has filed Form 4 at EDSA (Edesa Biotech, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.